U.S.-based entrepreneurs and innovators developing technology solutions for inequities in eye care can apply for the 2026 Regeneron Ophthalmology Health Equity Challenge.
Overview
The challenge is delivered by Regeneron with MATTER and focuses specifically on technology-enabled approaches that can reduce disparities in ophthalmology. Up to five finalists will be selected for a six-week incubator running from January 18 through February 26, 2027.
The finalists will refine their solutions, business models, and go-to-market strategies with expert support before presenting at a final showcase at Regeneron headquarters on March 2, 2027.
Benefits
- Finalist Award: Each selected finalist receives US$5,000.
- Top Award: One finalist receives an additional US$10,000 following the final showcase.
- Incubator: Up to five finalists participate in a six-week structured incubator.
- Mentorship: Participants receive mentoring and access to industry experts.
- Venture Support: The programme helps finalists strengthen the solution, business model, and go-to-market strategy.
- Final Showcase: Finalists present their work at Regeneron headquarters.
Eligibility
- Geography: Applicants must be based in the United States.
- Applicant Type: The challenge is intended for entrepreneurs and innovators.
- Sector: The solution must address ophthalmology or eye-care health equity.
- Technology: The proposed approach should be technology enabled.
- Impact: Applicants should demonstrate how the solution can reduce or address a defined inequity in eye care.
How to Apply
- Deadline: Applications close on November 22, 2026.
- Define the Inequity: Clearly identify the ophthalmology health-equity problem the solution addresses.
- Present the Solution: Explain the technology, users, evidence or progress, and expected impact.
- Submit: Complete the official MATTER challenge application before the deadline.
